X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9927) 9927
Publication (536) 536
Book Chapter (76) 76
Book Review (71) 71
Conference Proceeding (32) 32
Dissertation (23) 23
Newspaper Article (14) 14
Magazine Article (3) 3
Newsletter (3) 3
Web Resource (3) 3
Book / eBook (1) 1
Data Set (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3658) 3658
biochemistry & molecular biology (2110) 2110
animals (2086) 2086
humans (2074) 2074
alpha-glucosidase (1838) 1838
glucosidase (1789) 1789
enzymes (1408) 1408
chemistry, medicinal (1124) 1124
α-glucosidase (1121) 1121
kinetics (1105) 1105
food science & technology (1092) 1092
alpha-glucosidases - metabolism (1078) 1078
chemistry, organic (1021) 1021
enzyme inhibitors - pharmacology (1001) 1001
glycoside hydrolase inhibitors (997) 997
biotechnology & applied microbiology (946) 946
diabetes (934) 934
male (911) 911
beta-glucosidase (863) 863
rats (854) 854
pharmacology & pharmacy (852) 852
acarbose (793) 793
inhibitors (753) 753
chemistry, applied (728) 728
alpha-glucosidase inhibitors (714) 714
diabetes mellitus (701) 701
glucose (678) 678
enzyme inhibitors - chemistry (672) 672
hydrolysis (670) 670
molecular structure (664) 664
derivatives (659) 659
alpha-glucosidase inhibitor (657) 657
mice (656) 656
inhibition (650) 650
chemistry (641) 641
chemistry, multidisciplinary (626) 626
antioxidants (617) 617
analysis (616) 616
plant sciences (595) 595
beta-glucosidase - metabolism (583) 583
proteins (583) 583
structure-activity relationship (580) 580
purification (557) 557
antioxidant (548) 548
glycoside hydrolase inhibitors - pharmacology (536) 536
α-glucosidase inhibitor (535) 535
in-vitro (520) 520
hydrogen-ion concentration (514) 514
research (506) 506
plant extracts - pharmacology (503) 503
microbiology (502) 502
flavonoids (501) 501
female (500) 500
molecular sequence data (495) 495
hypoglycemic agents - pharmacology (489) 489
amylase (487) 487
plant extracts - chemistry (480) 480
glucosidases - antagonists & inhibitors (473) 473
glycoside hydrolase inhibitors - chemistry (471) 471
biotechnology (460) 460
substrate specificity (457) 457
alpha-amylase (437) 437
hyperglycemia (437) 437
identification (422) 422
α-amylase (395) 395
antioxidant activity (392) 392
alpha-amylases - antagonists & inhibitors (389) 389
fermentation (381) 381
β-glucosidase (381) 381
glycosylation (378) 378
leaves (375) 375
amylases (369) 369
molecular docking (365) 365
amino acid sequence (364) 364
alpha-glucosidases - chemistry (360) 360
nutrition & dietetics (360) 360
dose-response relationship, drug (358) 358
life sciences (358) 358
insulin (351) 351
polyphenols (349) 349
diabetes mellitus, type 2 - drug therapy (347) 347
type 2 diabetes (342) 342
metabolism (341) 341
organic chemistry (331) 331
beta-glucosidase - antagonists & inhibitors (329) 329
biochemistry, general (329) 329
research article (323) 323
cell biology (320) 320
glucosidases - metabolism (317) 317
temperature (314) 314
expression (310) 310
ethanol (309) 309
carbohydrates (307) 307
binding sites (305) 305
mechanism (305) 305
models, molecular (299) 299
hypoglycemic agents - therapeutic use (298) 298
cellulose (297) 297
glycosidase inhibitors (295) 295
oxidative stress (292) 292
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9770) 9770
Japanese (295) 295
Chinese (62) 62
German (44) 44
Korean (42) 42
Russian (32) 32
French (29) 29
Spanish (13) 13
Portuguese (7) 7
Czech (3) 3
Dutch (2) 2
Hungarian (2) 2
Italian (2) 2
Polish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 07/2014, Volume 13, Issue 1, pp. 110 - 110
Background: Alpha glucosidase inhibitor (GI) attenuates postprandial hyperglycemia (PPH) and reduces the risk of cardiovascular events in patients with... 
Dipeptidyl peptidase 4 (DPP-4) inhibitors | Endothelial function | Flow-mediated dilatation | Alpha glucosidase inhibitor | CD34 | PROGENITOR CELLS | DIPEPTIDYL PEPTIDASE-4 INHIBITOR | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | MYOCARDIAL-INFARCTION | VASCULAR-DISEASE | FLOW-MEDIATED VASODILATION | GLUCAGON-LIKE PEPTIDE-1 | ENDOCRINOLOGY & METABOLISM | CARDIOVASCULAR-DISEASE | JAPANESE PATIENTS | CORONARY-ARTERY-DISEASE | Prospective Studies | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Endothelium, Vascular - drug effects | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Endothelium, Vascular - physiology | Young Adult | Inositol - therapeutic use | Aged, 80 and over | Adult | Female | Sitagliptin Phosphate | Triazoles - therapeutic use | Inositol - pharmacology | Glycoside Hydrolase Inhibitors - pharmacology | Inositol - analogs & derivatives | Triazoles - pharmacology | Diabetes Mellitus, Type 2 - diagnosis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Pyrazines - pharmacology | Urine | Oxidative stress | Peptides | Internal medicine | Colleges & universities | Cardiovascular disease | Dentistry | Medicine | Hyperglycemia | Hospitals | Coronary vessels | Diabetes | Acute coronary syndromes | Drug dosages | Pharmaceutical sciences | Pharmaceuticals
Journal Article
Process Biochemistry, ISSN 1359-5113, 02/2018, Volume 65, pp. 228 - 232
[Display omitted] •New α-glucosidase inhibitors (aGIs) were isolated and identified from fermented Nutrient Broth.•All the isolated compounds are... 
α–glucosidase inhibitor | Diabetes | Microbial conversion | Paenibacillus sp | ENGINEERING, CHEMICAL | NEWLY ISOLATED STRAIN | 1-DEOXYNOJIRIMYCIN | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | alpha-glucosidase inhibitor | BIOCHEMISTRY & MOLECULAR BIOLOGY | PURIFICATION | FERMENTATION | IDENTIFICATION
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 07/2010, Volume 12, Issue 7, pp. 613 - 622
Objective: To compare the efficacy and safety of sitagliptin (a dipeptidyl peptidase‐4 inhibitor) and voglibose (an α‐glucosidase inhibitor) monotherapy in... 
DPP‐4 inhibitor | incretins | sitagliptin | α‐glucosidase inhibitor | MK‐0431 | glycaemic control | voglibose | dipeptidyl peptidase‐4 inhibitor | ONO‐5435 | antihyperglycaemic agents | Incretins | Dipeptidyl peptidase-4 inhibitor | α-glucosidase inhibitor | Antihyperglycaemic agents | DPP-4 inhibitor | Voglibose | Sitagliptin | ONO-5435 | MK-0431 | Glycaemic control | alpha-glucosidase inhibitor | dipeptidyl peptidase-4 inhibitor | ACARBOSE | MELLITUS | BODY-WEIGHT | THERAPY | GLUCAGON-LIKE PEPTIDE-1 | ALPHA-GLUCOSIDASE INHIBITORS | ENDOCRINOLOGY & METABOLISM | 1,5-ANHYDROGLUCITOL | DEGRADATION | AGENTS | PEPTIDASE-4 INHIBITOR SITAGLIPTIN | Triazoles - administration & dosage | Inositol - pharmacology | Double-Blind Method | Drug Administration Schedule | Humans | Middle Aged | Pyrazines - administration & dosage | Male | Treatment Outcome | Inositol - administration & dosage | Inositol - analogs & derivatives | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Hypoglycemic Agents - pharmacology | Triazoles - pharmacology | Asian Continental Ancestry Group | Hypoglycemic Agents - administration & dosage | Glycated Hemoglobin A | Female | Sitagliptin Phosphate | Diabetes Mellitus, Type 2 - drug therapy | Pyrazines - pharmacology | Type 2 diabetes | Medical colleges | Glycosylated hemoglobin | Clinical trials | Hypoglycemic agents | Glucose | Comparative analysis | Dextrose
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 08/2014, Volume 16, Issue 8, pp. 761 - 765
We assessed the efficacy and safety of sitagliptin compared with α‐glucosidase inhibitor (αGI) in 120 of Japanese patients with type 2 diabetes mellitus (T2DM)... 
type 2 diabetes | DPP‐IV inhibitor | sulphonylureas | α‐glucosidase inhibitor | randomized trial | Type 2 diabetes | Randomized trial | α-glucosidase inhibitor | Sulphonylureas | DPP-IV inhibitor | VOGLIBOSE | MONOTHERAPY | HYPERGLYCEMIA | THERAPY | alpha-glucosidase inhibitor | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | MELLITUS | Glycated Hemoglobin A - analysis | Triazoles - adverse effects | Glycoside Hydrolase Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Glycoside Hydrolase Inhibitors - therapeutic use | Male | Pyrazines - therapeutic use | Hypoglycemia - prevention & control | 1-Deoxynojirimycin - therapeutic use | Drug Therapy, Combination - adverse effects | Inositol - therapeutic use | Inositol - adverse effects | 1-Deoxynojirimycin - analogs & derivatives | Female | 1-Deoxynojirimycin - adverse effects | Sitagliptin Phosphate | Hypoglycemia - chemically induced | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Hyperglycemia - prevention & control | Japan | Sulfonylurea Compounds - therapeutic use | Inositol - analogs & derivatives | Diabetes Mellitus, Type 2 - blood | Gastrointestinal Agents - therapeutic use | Pyrazines - adverse effects | Aged | Gastrointestinal Agents - adverse effects | Diabetes Mellitus, Type 2 - drug therapy | alpha-Glucosidases - metabolism | alpha-Glucosidases - chemistry
Journal Article